Friday 6 November 2026
Export UHS’s income statement to Excel — free account
Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024.
- Revenue
- +5.30%
- EPS
- −9.98%
- Free cash flow
- +216.7%
- Total debt
- +21.7%
Quarter to September 2026, against a year earlier
194.62
3.97
−2.00%
Follow UHS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 8 | 8 | 8 |
+8 more TTM periods Free account |
| 40.04% | 20.81% | 21.12% | 21.14% | ||
| 8.99% | 9.87% | 9.95% | 9.93% | ||
ROIC |
9.42% | 10.46% | 10.53% | 10.43% | |
Return on Tangible Assets |
17.80% | 20.28% | 20.78% | 20.75% | |
Average Days of Receivables |
55.96 | 56.44 | 56.42 | 54.70 | |
Free Cash Flow per Share |
19.29 | 14.17 | 14.94 | 13.36 | |
Free Cash Flow |
1,133.90 | 845.40 | 912.69 | 849.25 | |
Capital Expenditures |
(922.28) | (954.90) | (993.28) | (1,015.15) | |
| Other line items | |||||
Cash ROIC |
8.37% | 6.72% | 7.39% | 6.94% | |
Accounts Receivable Turnover |
6.80 | 7.10 | 6.89 | 7.27 | |
Accounts Payable Turnover |
0.70 | 0.73 | 0.76 | 1.09 | |
Inventory Turnover |
7.35 | 7.39 | 7.46 | 7.32 | |
Average Days of Payables |
541.67 | 530.29 | 511.13 | 531.61 | |
Days of Inventory on Hand |
50.60 | 50.64 | 49.76 | 51.07 | |
Tax Rate |
(0.24) | (0.24) | (0.23) | (0.23) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.24% | 46.08% | 46.29% | 46.56% | |
Share Based Compensation of Revenue |
0.53% | 0.53% | 0.54% | 0.55% | |
Interest Coverage |
11.34 | 13.05 | 13.33 | 12.78 | |
Operating CF/Net income |
1.41 | 1.18 | 1.25 | 1.25 | |
Depreciation/Fixed assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Capex/Depreciation |
(1.40) | (1.49) | (1.59) | (1.64) | |
Revenue per Share |
312.15 | 303.64 | 290.81 | 273.11 | |
Operating CF per Share |
34.97 | 30.18 | 31.21 | 29.32 | |
Capex per Share |
(15.69) | (16.01) | (16.26) | (15.97) | |
Capex to Sales |
0.05 | 0.05 | 0.06 | 0.06 |
Columns are period end dates · fundamentals updated 2 Nov 2026